Evidence map›Paper›PMID 30268395›Full record

ArticleThe Journal of pediatrics2018

Exome-Wide Rare Variant Analyses in Sudden Infant Death Syndrome.

David J Tester, Leonie C H Wong, Pritha Chanana, Belinda Gray, Amie Jaye, Jared M Evans, Margaret Evans, Peter Fleming, Iona Jeffrey, Marta Cohen and 4 more

Abstract read
In one paragraph

Article in The Journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic Determinants of Sudden Unexpected Death in Pediatrics.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  9. De novo mutations in childhood cases of sudden unexplained death that disrupt intracellular CaProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Genetic Factors Underlying Sudden Infant Death Syndrome.The application of clinical genetics · 2021
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

David J TesterDepartment of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN.
Leonie C H WongMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom; Cardiology Clinical Academic Group, St George's University Hospitals' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Pritha ChananaDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Belinda GrayMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom; Cardiology Clinical Academic Group, St George's University Hospitals' National Health Service (NHS) Foundation Trust, London, United Kingdom; Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia.
Amie JayeMedical and Molecular Genetics, Guy's Hospital, King's College London, London, United Kingdom.
Jared M EvansDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN.
Margaret EvansDepartment of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Peter FlemingCentre for Child and Adolescent Health, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Iona JeffreyDepartment of Cellular Pathology, St George's University of London, London, United Kingdom; Department of Cellular Pathology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
Marta CohenHistopathology Department, Sheffield Children's Hospital NHS FT, Sheffield, United Kingdom.
Jacob Tfelt-HansenDepartment of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Michael A SimpsonMedical and Molecular Genetics, Guy's Hospital, King's College London, London, United Kingdom.
Elijah R BehrMolecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom; Cardiology Clinical Academic Group, St George's University Hospitals' National Health Service (NHS) Foundation Trust, London, United Kingdom.
Michael J AckermanDepartment of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN. Electronic address: ackerman.michael@mayo.edu.

Funding

Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)R01HD042569 · NICHD · MAYO CLINIC ROCHESTER · PI ACKERMAN, MICHAEL JOHN · 2002 to 2017
$6.9M
CONTROL OF HEMATOPOIESIS IN THE HUMAN FETAL LIVERK08HL001378 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI EMERSON, STEPHEN G · 1985 to 1985
–
British Heart Foundation FS/13/78/30520NICHD NIH HHS R01 HD042569
6 · The paper itself

Abstract

objectiveTo determine whether a monogenic basis explains sudden infant death syndrome (SIDS) using an exome-wide focus. STUDY

designA cohort of 427 unrelated cases of SIDS (257 male; average age = 2.7 ± 1.9 months) underwent whole-exome sequencing. Exome-wide rare variant analyses were carried out with 278 SIDS cases of European ancestry (173 male; average age = 2.7 ± 1.98 months) and 973 ethnic-matched controls based on 6 genetic models. Ingenuity Pathway Analysis also was performed. The cohort was collected in collaboration with coroners, medical examiners, and pathologists by St George's University of London, United Kingdom, and Mayo Clinic, Rochester, Minnesota. Whole-exome sequencing was performed at the Genomic Laboratory, Kings College London, United Kingdom, or Mayo Clinic's Medical Genome Facility, Rochester, Minnesota.

resultsAlthough no exome-wide significant (P < 2.5 × 10

conclusionsThe lack of exome-wide significant genetic associations indicates an extreme heterogeneity of etiologies underlying SIDS. Our approach to understanding the genetic mechanisms of SIDS has far reaching implications for the SIDS research community as a whole and may catalyze new evidence-based SIDS research across multiple disciplines. Perturbations in glucocorticoid biosynthesis may represent a novel SIDS-associated biological pathway for future SIDS investigative research.

Indexed as

ExomeGenetic Predisposition to DiseaseAutopsyCase-Control StudiesChildChild, PreschoolEthnicityFemaleGenetic VariationHumansInfantMaleMinnesotaMutationSudden Infant DeathUnited Kingdominherited cardiac conditionsmolecular autopsysudden infant death syndromewhole exome sequencing

Identifiers

PMID30268395
PMCPMC6394853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.